EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
-12.44%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.27B
AUM Growth
+$3.27B
Cap. Flow
-$78.2M
Cap. Flow %
-2.39%
Top 10 Hldgs %
61.39%
Holding
63
New
6
Increased
5
Reduced
5
Closed
8

Top Buys

1
MORF
Morphic Holding, Inc. Common Stock
MORF
$88.5M
2
JANX icon
Janux Therapeutics
JANX
$61.6M
3
CRGX
CARGO Therapeutics
CRGX
$24.1M
4
ITOS
iTeos Therapeutics
ITOS
$18.6M
5
BCYC
Bicycle Therapeutics
BCYC
$18.4M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
$81M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
$75.5M
3
ALEC icon
Alector
ALEC
$24.4M
4
NKTX icon
Nkarta
NKTX
$21.6M
5
OVID icon
Ovid Therapeutics
OVID
$18.7M

Sector Composition

1 Healthcare 99.88%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ADAP
26
Adaptimmune Therapeutics
ADAP
$13.9M
$26.7M 0.82%
27,404,070
– –
ORIC icon
27
Oric Pharmaceuticals
ORIC
$1.03B
$24.2M 0.74%
3,418,068
– –
CRGX
28
DELISTED
CARGO Therapeutics
CRGX
$24.1M 0.74%
+1,470,000
New +$24.1M
CLDX icon
29
Celldex Therapeutics
CLDX
$1.57B
$24.1M 0.74%
650,000
– –
PCVX icon
30
Vaxcyte
PCVX
$4.17B
$22.7M 0.69%
300,000
– –
EWTX icon
31
Edgewise Therapeutics
EWTX
$1.54B
$22.5M 0.69%
1,250,385
– –
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.34B
$21.9M 0.67%
1,346,475
-4,645,004
-78% -$75.5M
LENZ
33
LENZ Therapeutics
LENZ
$1.12B
$21.1M 0.65%
1,219,774
– –
MDGL icon
34
Madrigal Pharmaceuticals
MDGL
$9.7B
$21M 0.64%
75,000
– –
NMRA icon
35
Neumora Therapeutics
NMRA
$283M
$20.4M 0.62%
2,071,450
– –
BCYC
36
Bicycle Therapeutics
BCYC
$492M
$18.4M 0.56%
+910,000
New +$18.4M
AVIR icon
37
Atea Pharmaceuticals
AVIR
$275M
$18M 0.55%
5,441,896
-703,965
-11% -$2.33M
PHVS icon
38
Pharvaris
PHVS
$1.41B
$16.9M 0.52%
900,000
– –
DYN icon
39
Dyne Therapeutics
DYN
$1.92B
$15.1M 0.46%
427,039
– –
TECX
40
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$14M 0.43%
+849,143
New +$14M
RCKT icon
41
Rocket Pharmaceuticals
RCKT
$358M
$10.9M 0.33%
+508,393
New +$10.9M
KROS icon
42
Keros Therapeutics
KROS
$640M
$8.57M 0.26%
187,500
– –
KLRS
43
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
$8.17M 0.25%
11,294,585
– –
REPL icon
44
Replimune Group
REPL
$460M
$7.65M 0.23%
+850,341
New +$7.65M
VERV
45
DELISTED
Verve Therapeutics
VERV
$6.1M 0.19%
1,250,000
– –
GBIO icon
46
Generation Bio
GBIO
$40.3M
$5.77M 0.18%
2,046,867
– –
PRME icon
47
Prime Medicine
PRME
$595M
$3.6M 0.11%
700,000
– –
ATRA icon
48
Atara Biotherapeutics
ATRA
$88.7M
$3.46M 0.11%
406,679
-9,760,364
-96% -$26
PRQR icon
49
ProQR Therapeutics
PRQR
$256M
$3.39M 0.1%
2,042,771
-841,586
-29% -$1.4M
HOOK
50
DELISTED
HOOKIPA Pharma
HOOK
$3.38M 0.1%
5,717,324
+1,122,300
+24% +$664K
1
2
3